The demonstration of the benefit of Trizivir is mainly based on results of studies performed in treatment naive patients or moderately antiretroviral experienced patients with non-advanced disease.
Trizivir’ i soodne toime on peamiselt tõestatud uuringutes, kus osalesid varem ravi mittesaanud patsiendid või keskmist retroviiruste vastast ravi saanud progresseerumata haigusega patsiendid.